JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801408200 on June 14, 2008

J. Biol. Chem., Vol. 283, Issue 34, 22930-22941, August 22, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/34/22930    most recent
M801408200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Zhu, X.
Right arrow Articles by Parks, J. S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, X.
Right arrow Articles by Parks, J. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Increased Cellular Free Cholesterol in Macrophage-specific Abca1 Knock-out Mice Enhances Pro-inflammatory Response of Macrophages*Formula

Xuewei Zhu{ddagger}, Ji-Young Lee{ddagger}, Jenelle M. Timmins{ddagger}, J. Mark Brown{ddagger}, Elena Boudyguina{ddagger}, Anny Mulya{ddagger}, Abraham K. Gebre{ddagger}, Mark C. Willingham§, Elizabeth M. Hiltbold, Nilamadhab Mishra||, Nobuyo Maeda**, and John S. Parks{ddagger}1

From the Departments of {ddagger}Pathology/Lipid Sciences, §Pathology/Tumor Biology, Microbiology and Immunology, and ||Internal Medicine/Rheumatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157 and the **Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina 27599

Macrophage-specific Abca1 knock-out (Abca1M/–M) mice were generated to determine the role of macrophage ABCA1 expression in plasma lipoprotein concentrations and the innate immune response of macrophages. Plasma lipid and lipoprotein concentrations in chow-fed Abca1M/–M and wild-type (WT) mice were indistinguishable. Compared with WT macrophages, Abca1M/–M macrophages had a >95% reduction in ABCA1 protein, failed to efflux lipid to apoA-I, and had a significant increase in free cholesterol (FC) and membrane lipid rafts without induction of endoplasmic reticulum stress. Lipopolysaccharide (LPS)-treated Abca1M/–M macrophages exhibited enhanced expression of pro-inflammatory cytokines and increased activation of the NF-{kappa}B and MAPK pathways, which could be diminished by silencing MyD88 or by chemical inhibition of NF-{kappa}B or MAPK. In vivo LPS injection also resulted in a higher pro-inflammatory response in Abca1M/–M mice compared with WT mice. Furthermore, cholesterol depletion of macrophages with methyl-β-cyclodextrin normalized FC content between the two genotypes and their response to LPS; cholesterol repletion of macrophages resulted in increased cellular FC accumulation and enhanced cellular response to LPS. Our results suggest that macrophage ABCA1 expression may protect against atherosclerosis by facilitating the net removal of excess lipid from macrophages and dampening pro-inflammatory MyD88-dependent signaling pathways by reduction of cell membrane FC and lipid raft content.


Received for publication, February 21, 2008 , and in revised form, June 13, 2008.

* This work was supported, in whole or in part, by National Institutes of Health Grants HL49373, HL54176, and AT27820 (to J. S. P.) and HL07115 (cardiovascular pathology training grant; to J. M. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental "Experimental Procedures," Figs. S1–S3, and Table S1.

1 To whom correspondence should be addressed: Dept. of Pathology/Lipid Sciences, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157. Tel.: 336-716-2145; Fax: 336-716-6279; E-mail: jparks{at}wfubmc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
L. Yvan-Charvet, C. Welch, T. A. Pagler, M. Ranalletta, M. Lamkanfi, S. Han, M. Ishibashi, R. Li, N. Wang, and A. R. Tall
Increased Inflammatory Gene Expression in ABC Transporter-Deficient Macrophages: Free Cholesterol Accumulation, Increased Signaling via Toll-Like Receptors, and Neutrophil Infiltration of Atherosclerotic Lesions
Circulation, October 28, 2008; 118(18): 1837 - 1847.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.